Syed Research Consultants, LLC

Sheffield, Alabama 35660

1 studies enrolling now · 14 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Cardiovascular Diseases, Chronic Kidney Disease, Chronic Kidney Diseases, Diabetes Mellitus, Type 2, Dyslipidemias, Familial Hypercholesterolemia, Gout, Gout Flare, Heart Failure, High Cholesterol, Hypercholesterolemia

Studies at this site

• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
• A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone — Completed
• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk — Completed
• Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies — Completed
• A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1) — Completed
• Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients — Completed
• A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood Pressure — Completed
• Benefits of Microcor in Ambulatory Decompensated Heart Failure — Completed
• A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin — Completed
• A Study of LY3437943 in Participants With Type 2 Diabetes — Completed
• Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease — Stopped early
• A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus — Completed
• A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes — Completed
• Linagliptin as Add on to Basal Insulin in the Elderly — Completed